These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25063398)

  • 1. Contrast echocardiography for assessment of left ventricular thrombi.
    Abdelmoneim SS; Pellikka PA; Mulvagh SL
    J Ultrasound Med; 2014 Aug; 33(8):1337-44. PubMed ID: 25063398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Italian Society of Cardiovascular Echography (SIEC) Consensus Conference on the state of the art of contrast echocardiography.
    Ital Heart J; 2004 Apr; 5(4):309-34. PubMed ID: 15185894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of intracardiac masses in patients with coronary artery disease using cardiac magnetic resonance imaging: a comparison with transthoracic echocardiography.
    Staab W; Bergau L; Schuster A; Hinojar R; Dorenkamp M; Obenauer S; Lotz J; Sohns C
    Int J Cardiovasc Imaging; 2014 Mar; 30(3):647-57. PubMed ID: 24384859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical applications of contrast echocardiography.
    Olszewski R; Timperley J; Szmigielski C; Monaghan M; Nihoyannopoulos P; Senior R; Becher H
    Eur J Echocardiogr; 2007 Jun; 8(3):S13-23. PubMed ID: 17481562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical application and laboratory protocols for performing contrast echocardiography.
    Chong A; Haluska B; Wahi S
    Indian Heart J; 2013; 65(3):337-46. PubMed ID: 23809394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visualization of ventricular thrombi with contrast-enhanced magnetic resonance imaging in patients with ischemic heart disease.
    Mollet NR; Dymarkowski S; Volders W; Wathiong J; Herbots L; Rademakers FE; Bogaert J
    Circulation; 2002 Dec; 106(23):2873-6. PubMed ID: 12460863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of contrast echocardiography for assessment of intracardiac masses.
    Mansencal N; Revault-d'Allonnes L; Pelage JP; Farcot JC; Lacombe P; Dubourg O
    Arch Cardiovasc Dis; 2009 Mar; 102(3):177-83. PubMed ID: 19375671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved echocardiographic delineation of left ventricular thrombus with the use of intravenous second-generation contrast image enhancement.
    Thanigaraj S; Schechtman KB; Pérez JE
    J Am Soc Echocardiogr; 1999 Dec; 12(12):1022-6. PubMed ID: 10588776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of contrast echocardiography for left ventricular thrombus detection postinfarction and impact on antithrombotic therapy.
    Siebelink HM; Scholte AJ; Van de Veire NR; Holman ER; Nucifora G; van der Wall EE; Bax JJ
    Coron Artery Dis; 2009 Nov; 20(7):462-6. PubMed ID: 19877307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of ultrasound contrast agents in current clinical practice with special focus on DEFINITY
    Salih M; Ali SM; Jena N; Ananthasubramaniam K
    Future Cardiol; 2021 Mar; 17(2):197-214. PubMed ID: 32897099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast echocardiography in critical care: echoes of the future? A review of the role of microsphere contrast echocardiography.
    Platts DG; Fraser JF
    Crit Care Resusc; 2011 Mar; 13(1):44-55. PubMed ID: 21355829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress echocardiography with contrast for the diagnosis of coronary artery disease: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(10):1-59. PubMed ID: 23074387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced anatomic imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus.
    Weinsaft JW; Kim RJ; Ross M; Krauser D; Manoushagian S; LaBounty TM; Cham MD; Min JK; Healy K; Wang Y; Parker M; Roman MJ; Devereux RB
    JACC Cardiovasc Imaging; 2009 Aug; 2(8):969-79. PubMed ID: 19679285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation.
    Srichai MB; Junor C; Rodriguez LL; Stillman AE; Grimm RA; Lieber ML; Weaver JA; Smedira NG; White RD
    Am Heart J; 2006 Jul; 152(1):75-84. PubMed ID: 16824834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncommon intraventricular thrombus formation between the posterior mitral leaflet and the lateral left ventricular wall.
    Butz T; Faber L; Langer C; Esdorn H; Körfer J; Wiemer M; Horstkotte D
    Eur J Echocardiogr; 2008 Jan; 9(1):199-200. PubMed ID: 18267924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombi in Takotsubo syndrome: Are there implications for management and cryptogenic thromboembolism in general?
    Madias JE
    Int J Cardiol; 2015 Apr; 185():1. PubMed ID: 25777279
    [No Abstract]   [Full Text] [Related]  

  • 17. [Left ventricular opacification: improved detection of global and regional wall motion at rest].
    Touche T
    Ann Cardiol Angeiol (Paris); 2002 Sep; 51(4):203-4. PubMed ID: 12471799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: comparison with cine magnetic resonance imaging.
    Hundley WG; Kizilbash AM; Afridi I; Franco F; Peshock RM; Grayburn PA
    J Am Coll Cardiol; 1998 Nov; 32(5):1426-32. PubMed ID: 9809958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of contrast computed tomography to detect left ventricular apical thrombus associated with takotsubo cardiomyopathy.
    Ouchi K; Nakamura F; Ikutomi M; Oshima T; Ishiwata J; Shinohara H; Kouzaki T; Amaki T
    Heart Vessels; 2016 May; 31(5):822-7. PubMed ID: 25630714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial.
    Cohen JL; Cheirif J; Segar DS; Gillam LD; Gottdiener JS; Hausnerova E; Bruns DE
    J Am Coll Cardiol; 1998 Sep; 32(3):746-52. PubMed ID: 9741522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.